(IN BRIEF) The Global Cybersecurity Outlook 2025 report from the World Economic Forum highlights the rising complexity of cybersecurity challenges, particularly in supply chains, geopolitical ...

(IN BRIEF) The Global Cybersecurity Outlook 2025 report from the World Economic Forum highlights the rising complexity of cybersecurity challenges, particularly in supply chains, geopolitical ...

(IN BRIEF) Solvay and Hankook have signed a Memorandum of Understanding (MOU) to develop circular silica derived from biosourced and waste materials for tire production. This collaboration leverages ...

(IN BRIEF) The Global Cybersecurity Outlook 2025 report from the World Economic Forum highlights the rising complexity of cybersecurity challenges, particularly in supply chains, geopolitical ...

(IN BRIEF) The Global Cybersecurity Outlook 2025 report from the World Economic Forum highlights the rising complexity of cybersecurity challenges, particularly in supply chains, geopolitical ...

(IN BRIEF) Savills has appointed Joel Gazeres to its Operational Capital Markets (OCM) division, where he will focus on growing the Healthcare and Senior Living team. Gazeres joins from CBRE, bringing ...

(IN BRIEF) Savills has appointed Joel Gazeres to its Operational Capital Markets (OCM) division, where he will focus on growing the Healthcare and Senior Living team. Gazeres joins from CBRE, bringing ...

(IN BRIEF) Solvay and Hankook have signed a Memorandum of Understanding (MOU) to develop circular silica derived from biosourced and waste materials for tire production. This collaboration leverages ...

(IN BRIEF) Solvay and Hankook have signed a Memorandum of Understanding (MOU) to develop circular silica derived from biosourced and waste materials for tire production. This collaboration leverages ...

(IN BRIEF) Sarclisa, an anti-CD38 treatment developed by Sanofi, has been approved in China for treating adult patients with relapsed or refractory multiple myeloma (R/R MM) who have received at least ...

A prototype of the Liverpool Diagnostic Infrared Wand (LDIR Wand), developed by the University of Liverpool in collaboration with the Liverpool H ...

(IN BRIEF) Sarclisa, an anti-CD38 treatment developed by Sanofi, has been approved in China for treating adult patients with relapsed or refractory multiple myeloma (R/R MM) who have received at least ...